FDA Halts Dual COVID-Flu Vaccine Trial Over Safety Concern

By Jessica Karins / October 16, 2024 at 5:19 PM

FDA has placed a clinical hold on the dual COVID-19 and influenza vaccine trial from protein-based vaccine manufacturer Novavax, the company announced Wednesday (Oct. 16), due to a report of a serious adverse event of motor neuropathy.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.